Insider filing · PCVX
Harpreet S. Dhaliwal
Chief Technical Ops Officer
profile →
Vaxcyte, Inc.
PCVX · Healthcare · 37 filings in 24 months
ticker →
Harpreet S. Dhaliwal sold $455K of Vaxcyte (PCVX)
Executed Dec 31 2025, disclosed Jan 2, 2 days later.
Value, as filed
$455K
9,743 sh × $46.69
Executed
Dec 31 2025
the trade date, as filed
Disclosed
Jan 2
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
HDHarpreet S. Dhaliwal (Chief Technical Ops Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Vaxcyte, Inc. (PCVX). The largest single filing was $935K of PCVX (17,000 sh × $55.00, as filed), executed Aug 5.
The name
PCVXHealthcare · Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial inf…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Harpreet S. Dhaliwal in PCVX
PCVXSALE
Vaxcyte, Inc.
$935K17,000 sh × $55.00
Exec Aug 5
Filed Aug 5 · 7:01 PM ET